News & Updates

Eating disorders tied to nighttime eating, menopausal symptom severity

05 Mar 2025

Climacteric women with eating disorders are more likely to exhibit night eating habits and experience more severe symptoms of menopause, as reported in a descriptive study.

Eating disorders tied to nighttime eating, menopausal symptom severity

05 Mar 2025

HPV infection ups risk of new-onset hidradenitis suppurativa

05 Mar 2025

Infection with the human papillomavirus (HPV) contributes to an increased risk of developing hidradenitis suppurativa (HS), indicating a potential association, reveals a study.

HPV infection ups risk of new-onset hidradenitis suppurativa

05 Mar 2025

Leisure-time physical activity helps prevent hepatic steatosis

05 Mar 2025 by

Leisure-time physical activity (PA) offers protection against hepatic steatosis, with greater benefits seen among women and young people, suggests a study. Additionally, increasing leisure-time PA in men helps prevent liver fibrosis.

Leisure-time physical activity helps prevent hepatic steatosis

05 Mar 2025

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

05 Mar 2025

Treatment with 5-fluorouracil (5-FU) 5% cream tends to end in failure with shorter treatment duration and larger lesion size in patients with squamous cell carcinoma in situ (SCCis), a study has shown.

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

05 Mar 2025

EV-302 2-year updates: EV+P maintains transformative benefit in bladder cancer

05 Mar 2025 by

The updated analysis of the phase III EV-302 trial continues to show the benefit of front-line enfortumab vedotin plus pembrolizumab (EV+P) compared with chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).

EV-302 2-year updates: EV+P maintains transformative benefit in bladder cancer

05 Mar 2025

Once-weekly semaglutide shows promise in alcohol use disorder

05 Mar 2025 by

Low-dose semaglutide may reduce alcohol craving and some drinking-related outcomes in patients with alcohol use disorder (AUD), a randomized clinical trial has shown.

Once-weekly semaglutide shows promise in alcohol use disorder

05 Mar 2025

GLP-1 receptor agonists reduce more fat than muscle mass

05 Mar 2025 by

Glucagon-like peptide-1 (GLP-1) receptor agonists likely induce weight loss by reducing more fat mass than muscle mass, a research team from the University of Hong Kong (HKU) has found.

GLP-1 receptor agonists reduce more fat than muscle mass

05 Mar 2025

No cardiovascular signal with anti-CGRP mAbs for migraine

05 Mar 2025

Migraine treatment with monoclonal antibodies (mAbs) targeting calcitonin gene-related peptide (CGRP) or its receptor does not appear to contribute to increased risk of cardiovascular disease (CVD) compared with onabotulinumtoxinA in adults, including those who are older and with disability, according to a retrospective cohort study.

No cardiovascular signal with anti-CGRP mAbs for migraine

05 Mar 2025

Frontline nivolumab plus ipilimumab ups OS, ORR in patients with uHCC

05 Mar 2025 by

The combination of nivolumab and ipilimumab (NIVO + IPI) significantly improves overall survival (OS) and objective response rate (ORR) compared with lenvatinib or sorafenib (LEN/SOR) in the first-line setting for patients with unresectable hepatocellular carcinoma (uHCC), based on the CheckMate 9DW expanded analyses presented at ASCO GI 2025.

Frontline nivolumab plus ipilimumab ups OS, ORR in patients with uHCC

05 Mar 2025

De-escalating ticagrelor monotherapy reduces bleeding in ACS

04 Mar 2025

De-escalation of dual antiplatelet therapy (DAPT) to ticagrelor monotherapy results in a decreased risk for major bleeding compared with standard DAPT among patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, reports a study.

De-escalating ticagrelor monotherapy reduces bleeding in ACS

04 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Eating disorders tied to nighttime eating, menopausal symptom severity

Eating disorders tied to nighttime eating, menopausal symptom severity

HPV infection ups risk of new-onset hidradenitis suppurativa

HPV infection ups risk of new-onset hidradenitis suppurativa

Leisure-time physical activity helps prevent hepatic steatosis

Leisure-time physical activity helps prevent hepatic steatosis

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

EV-302 2-year updates: EV+P maintains transformative benefit in bladder cancer

EV-302 2-year updates: EV+P maintains transformative benefit in bladder cancer

Once-weekly semaglutide shows promise in alcohol use disorder

Once-weekly semaglutide shows promise in alcohol use disorder

GLP-1 receptor agonists reduce more fat than muscle mass

GLP-1 receptor agonists reduce more fat than muscle mass

No cardiovascular signal with anti-CGRP mAbs for migraine

No cardiovascular signal with anti-CGRP mAbs for migraine

Frontline nivolumab plus ipilimumab ups OS, ORR in patients with uHCC

Frontline nivolumab plus ipilimumab ups OS, ORR in patients with uHCC

De-escalating ticagrelor monotherapy reduces bleeding in ACS

De-escalating ticagrelor monotherapy reduces bleeding in ACS